Document and Entity Information
Document and Entity Information | Sep. 18, 2024 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Sep. 18, 2024 |
Entity Registrant Name | Elevation Oncology, Inc. |
Securities Act File Number | 001-40523 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 84-1771427 |
Entity Address, Address Line One | 101 Federal Street |
Entity Address, Address Line Two | Suite 1900 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02110 |
City Area Code | 716 |
Local Phone Number | 371-1125 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | ELEV |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001783032 |
Amendment Flag | false |